BLRX logo

BioLineRx (BLRX) Return On Equity

Annual ROE

-189.23%
-147.27%-350.98%

December 31, 2023


Summary


Performance

BLRX ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBLRXprofitabilitymetrics:

Quarterly ROE

-160.88%
+41.39%+20.46%

September 1, 2024


Summary


Performance

BLRX Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBLRXprofitabilitymetrics:

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

BLRX ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-351.0%0.0%
3 y3 years-74.6%0.0%
5 y5 years-288.2%0.0%

BLRX ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-351.0%at low-403.4%+34.8%
5 y5-year-351.0%at low-403.4%+34.8%
alltimeall time-421.7%at low-990.3%+34.8%

BioLineRx ROE History

DateAnnualQuarterly
Sep 2024
-
-160.88%(-20.5%)
Jun 2024
-
-202.27%(-18.0%)
Mar 2024
-
-246.76%(+11.8%)
Dec 2023
-189.23%(+351.0%)
-220.63%(+51.1%)
Sep 2023
-
-146.00%(+50.5%)
Jun 2023
-
-97.01%(+60.0%)
Mar 2023
-
-60.62%(+43.1%)
Dec 2022
-41.96%(-30.1%)
-42.37%(+13.3%)
Sep 2022
-
-37.40%(+11.2%)
Jun 2022
-
-33.64%(+5.3%)
Mar 2022
-
-31.96%(-29.2%)
Dec 2021
-60.04%(-44.6%)
-45.16%(-33.4%)
Sep 2021
-
-67.77%(-13.5%)
Jun 2021
-
-78.38%(-21.0%)
Mar 2021
-
-99.18%(-8.9%)
Dec 2020
-108.36%(+59.0%)
-108.81%(+21.0%)
Sep 2020
-
-89.93%(+13.7%)
Jun 2020
-
-79.09%(+15.1%)
Mar 2020
-
-68.70%(+8.8%)
Dec 2019
-68.13%(+39.8%)
-63.12%(+24.2%)
Sep 2019
-
-50.84%(-7.1%)
Jun 2019
-
-54.73%(+6.5%)
Mar 2019
-
-51.39%(+2.9%)
Dec 2018
-48.75%(-12.0%)
-49.92%(+0.3%)
Sep 2018
-
-49.79%(+3.0%)
Jun 2018
-
-48.36%(-4.4%)
Mar 2018
-
-50.57%(-0.3%)
DateAnnualQuarterly
Dec 2017
-55.40%(+44.5%)
-50.72%(+7.6%)
Sep 2017
-
-47.12%(+7.4%)
Jun 2017
-
-43.88%(+0.9%)
Mar 2017
-
-43.48%(+15.1%)
Dec 2016
-38.34%(+5.7%)
-37.76%(+11.9%)
Sep 2016
-
-33.73%(+28.8%)
Jun 2016
-
-26.19%(-3.4%)
Mar 2016
-
-27.12%(-11.1%)
Dec 2015
-36.27%(-28.7%)
-30.49%(-12.1%)
Sep 2015
-
-34.69%(-4.0%)
Jun 2015
-
-36.13%(-5.0%)
Mar 2015
-
-38.05%(-9.4%)
Dec 2014
-50.89%(-60.1%)
-41.98%(-12.8%)
Sep 2014
-
-48.14%(-33.9%)
Jun 2014
-
-72.86%(-9.8%)
Mar 2014
-
-80.79%(-24.9%)
Dec 2013
-127.56%(+17.2%)
-107.53%(-8.7%)
Sep 2013
-
-117.76%(+7.4%)
Jun 2013
-
-109.60%(+19.3%)
Mar 2013
-
-91.85%(-4.3%)
Dec 2012
-108.87%(+86.0%)
-96.00%(+34.4%)
Sep 2012
-
-71.41%(+40.3%)
Jun 2012
-
-50.90%(-5.4%)
Mar 2012
-
-53.80%(+11.2%)
Dec 2011
-58.52%
-48.38%(-8.8%)
Sep 2011
-
-53.03%(-393.5%)
Jun 2011
-
18.07%(+81.4%)
Mar 2011
-
9.96%

FAQ

  • What is BioLineRx annual return on equity?
  • What is the all time high annual ROE for BioLineRx?
  • What is BioLineRx annual ROE year-on-year change?
  • What is BioLineRx quarterly return on equity?
  • What is the all time high quarterly ROE for BioLineRx?
  • What is BioLineRx quarterly ROE year-on-year change?

What is BioLineRx annual return on equity?

The current annual ROE of BLRX is -189.23%

What is the all time high annual ROE for BioLineRx?

BioLineRx all-time high annual return on equity is -36.27%

What is BioLineRx annual ROE year-on-year change?

Over the past year, BLRX annual return on equity has changed by -147.27% (-350.98%)

What is BioLineRx quarterly return on equity?

The current quarterly ROE of BLRX is -160.88%

What is the all time high quarterly ROE for BioLineRx?

BioLineRx all-time high quarterly return on equity is 18.07%

What is BioLineRx quarterly ROE year-on-year change?

Over the past year, BLRX quarterly return on equity has changed by 0.00% (0.00%)